HEADER HYDROLASE/HYDROLASE INHIBITOR 03-APR-98 1A86 TITLE MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MMP-8; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.24.34; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS COLLAGENASE, MATRIX METALLOPROTEINASE, MALONIC ACID, MMP8, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.BRANDSTETTER,E.G.V.ROEDERN,F.GRAMS,R.A.ENGH REVDAT 3 13-JUL-11 1A86 1 VERSN REVDAT 2 24-FEB-09 1A86 1 VERSN REVDAT 1 04-MAY-99 1A86 0 JRNL AUTH H.BRANDSTETTER,R.A.ENGH,E.G.VON ROEDERN,L.MORODER,R.HUBER, JRNL AUTH 2 W.BODE,F.GRAMS JRNL TITL STRUCTURE OF MALONIC ACID-BASED INHIBITORS BOUND TO HUMAN JRNL TITL 2 NEUTROPHIL COLLAGENASE. A NEW BINDING MODE EXPLAINS JRNL TITL 3 APPARENTLY ANOMALOUS DATA. JRNL REF PROTEIN SCI. V. 7 1303 1998 JRNL REFN ISSN 0961-8368 JRNL PMID 9655333 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1247 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A86 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : DEC-95 REMARK 200 TEMPERATURE (KELVIN) : 283 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.57000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.31000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.71500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.31000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.57000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.71500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLY A 242 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 145 -118.33 34.00 REMARK 500 HIS A 147 46.07 -148.43 REMARK 500 SER A 151 74.48 -154.95 REMARK 500 ASN A 157 -157.91 60.89 REMARK 500 THR A 185 -161.31 -126.53 REMARK 500 TYR A 241 -107.44 -107.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 0ZB A 1 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 996 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 137 O REMARK 620 2 GLY A 169 O 163.7 REMARK 620 3 GLY A 171 O 105.4 91.0 REMARK 620 4 ASP A 173 OD1 83.7 98.2 84.9 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 997 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLY A 155 O REMARK 620 2 ASN A 157 O 89.4 REMARK 620 3 ILE A 159 O 173.9 93.6 REMARK 620 4 GLU A 180 OE2 91.3 84.8 94.3 REMARK 620 5 ASP A 154 OD1 95.0 94.1 79.4 173.5 REMARK 620 6 ASP A 177 OD2 87.7 175.6 89.6 91.9 89.4 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 998 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 147 NE2 REMARK 620 2 ASP A 149 OD2 109.2 REMARK 620 3 HIS A 162 NE2 113.9 111.7 REMARK 620 4 HIS A 175 ND1 113.2 97.1 110.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 999 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 197 NE2 REMARK 620 2 HIS A 201 NE2 100.2 REMARK 620 3 HIS A 207 NE2 111.8 93.3 REMARK 620 4 0ZB A 1 O1 111.8 139.6 96.9 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-BENZYL-N~2~-[(2R)-2-(HYDROXYCARBAMOYL)-4- REMARK 630 METHYLPENTANOYL]-L-ALPHA-ASPARAGINE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0ZB A 1 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: HMI ASP ABN REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZB A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 996 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 997 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 998 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 999 DBREF 1A86 A 85 242 UNP P22894 MM08_HUMAN 105 262 SEQRES 1 A 158 ASN PRO LYS TRP GLU ARG THR ASN LEU THR TYR ARG ILE SEQRES 2 A 158 ARG ASN TYR THR PRO GLN LEU SER GLU ALA GLU VAL GLU SEQRES 3 A 158 ARG ALA ILE LYS ASP ALA PHE GLU LEU TRP SER VAL ALA SEQRES 4 A 158 SER PRO LEU ILE PHE THR ARG ILE SER GLN GLY GLU ALA SEQRES 5 A 158 ASP ILE ASN ILE ALA PHE TYR GLN ARG ASP HIS GLY ASP SEQRES 6 A 158 ASN SER PRO PHE ASP GLY PRO ASN GLY ILE LEU ALA HIS SEQRES 7 A 158 ALA PHE GLN PRO GLY GLN GLY ILE GLY GLY ASP ALA HIS SEQRES 8 A 158 PHE ASP ALA GLU GLU THR TRP THR ASN THR SER ALA ASN SEQRES 9 A 158 TYR ASN LEU PHE LEU VAL ALA ALA HIS GLU PHE GLY HIS SEQRES 10 A 158 SER LEU GLY LEU ALA HIS SER SER ASP PRO GLY ALA LEU SEQRES 11 A 158 MET TYR PRO ASN TYR ALA PHE ARG GLU THR SER ASN TYR SEQRES 12 A 158 SER LEU PRO GLN ASP ASP ILE ASP GLY ILE GLN ALA ILE SEQRES 13 A 158 TYR GLY HET 0ZB A 1 31 HET CA A 996 1 HET CA A 997 1 HET ZN A 998 1 HET ZN A 999 1 HETNAM 0ZB N-BENZYL-N~2~-[(2R)-2-(HYDROXYCARBAMOYL)-4- HETNAM 2 0ZB METHYLPENTANOYL]-L-ALPHA-ASPARAGINE HETNAM CA CALCIUM ION HETNAM ZN ZINC ION FORMUL 2 0ZB C18 H25 N3 O6 FORMUL 3 CA 2(CA 2+) FORMUL 5 ZN 2(ZN 2+) HELIX 1 1 GLU A 106 ALA A 123 1 18 HELIX 2 2 LEU A 191 SER A 202 1 12 HELIX 3 3 GLN A 231 ILE A 240 1 10 SHEET 1 A 5 ILE A 127 ARG A 130 0 SHEET 2 A 5 ASN A 92 ILE A 97 1 N LEU A 93 O ILE A 127 SHEET 3 A 5 ILE A 138 TYR A 143 1 N ILE A 138 O ARG A 96 SHEET 4 A 5 ALA A 174 ASP A 177 1 N ALA A 174 O ALA A 141 SHEET 5 A 5 ALA A 161 ALA A 163 -1 N HIS A 162 O HIS A 175 LINK CA CA A 996 O ASP A 137 1555 1555 2.25 LINK CA CA A 996 O GLY A 169 1555 1555 2.14 LINK CA CA A 996 O GLY A 171 1555 1555 2.20 LINK CA CA A 997 O GLY A 155 1555 1555 2.14 LINK CA CA A 997 O ASN A 157 1555 1555 2.21 LINK CA CA A 997 O ILE A 159 1555 1555 2.20 LINK CA CA A 997 OE2 GLU A 180 1555 1555 2.19 LINK ZN ZN A 998 NE2 HIS A 147 1555 1555 2.11 LINK ZN ZN A 998 OD2 ASP A 149 1555 1555 1.98 LINK ZN ZN A 998 NE2 HIS A 162 1555 1555 2.10 LINK ZN ZN A 998 ND1 HIS A 175 1555 1555 2.15 LINK ZN ZN A 999 NE2 HIS A 197 1555 1555 1.99 LINK ZN ZN A 999 NE2 HIS A 201 1555 1555 2.19 LINK ZN ZN A 999 NE2 HIS A 207 1555 1555 1.95 LINK CA CA A 996 OD1 ASP A 173 1555 1555 2.42 LINK CA CA A 997 OD1 ASP A 154 1555 1555 2.52 LINK CA CA A 997 OD2 ASP A 177 1555 1555 2.41 LINK O1 0ZB A 1 ZN ZN A 999 1555 1555 1.87 CISPEP 1 ASN A 188 TYR A 189 0 -0.80 SITE 1 AC1 14 THR A 129 ILE A 159 LEU A 160 ALA A 161 SITE 2 AC1 14 HIS A 197 GLU A 198 HIS A 201 HIS A 207 SITE 3 AC1 14 LEU A 214 TYR A 216 PRO A 217 ASN A 218 SITE 4 AC1 14 TYR A 219 ZN A 999 SITE 1 AC2 4 ASP A 137 GLY A 169 GLY A 171 ASP A 173 SITE 1 AC3 6 ASP A 154 GLY A 155 ASN A 157 ILE A 159 SITE 2 AC3 6 ASP A 177 GLU A 180 SITE 1 AC4 4 HIS A 147 ASP A 149 HIS A 162 HIS A 175 SITE 1 AC5 4 0ZB A 1 HIS A 197 HIS A 201 HIS A 207 CRYST1 33.140 69.430 72.620 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030175 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014403 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013770 0.00000 MASTER 313 0 5 3 5 0 9 6 0 0 0 13 END